Composition
- Active ingredients
- REGADENOSON 0.4MG/5ML (0.08MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA213236-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA216437-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA213210-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA215955-001 · Discontinued
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA217455-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA207320-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA214252-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA218054-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionThis page
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA213856-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA215827-001 · Prescription
- REGADENOSON 0.4MG/5ML (0.08MG/ML) · SolutionANDA212806-001 · Prescription
At a glance
- Brand name
- Regadenoson
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Apotex
- Status
- Prescription
- FDA approval
- 11 Apr 2022
- Application
- ANDA207604-001